In addition to the previous observations in animal models, our data supported the hypothesis that the involvement of dysregulated YY1 in NAFLD is mainly mediated by the dysregulation of the DNL pathway (Lu et al, 2014; Lai et al, 2018). This evidence concerns the gene YY1 and metabolic dysfunction-associated steatotic liver disease.